2011•Antimicrobial Agents and ChemotherapyOpen access

Double-Carbapenem Therapy for Carbapenemase-Producing Klebsiella pneumoniae

Catharine C. Bulik, David P. Nicolau

Abstract

The limited treatment options available for carbapenemase-producing Klebsiella pneumoniae (KPC) have made it a formidable pathogen. Previously we have shown the enhanced activity of pharmacodynamically optimized doripenem against KPC. Capitalizing on KPC's increased affinity for ertapenem, we evaluated the efficacy of a combination of ertapenem and doripenem in both an in vitro chemostat and an in vivo murine thigh infection model. Overall, the combination of doripenem plus ertapenem demonstrated enhanced efficacy over either agent alone.

About this research paper

What this paper is about

Why it matters

OpenAlex reports 200 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Ertapenem, Doripenem, Klebsiella pneumoniae, Carbapenem, Meropenem, Microbiology, In vivo, Medicine